Efficacy and safety of aerosolized tobramycin in cystic fibrosis
@article{Pai2001EfficacyAS, title={Efficacy and safety of aerosolized tobramycin in cystic fibrosis}, author={V. Pai and M. Nahata}, journal={Pediatric Pulmonology}, year={2001}, volume={32} }
Aerosolized tobramycin has been extensively used in cystic fibrosis (CF) patients in order to directly deliver the antibiotic to the endobronchial site of infection, and decrease toxicity by limiting systemic absorption. Aerosolized tobramycin doses ranging from 80 mg twice or three times daily to 600 mg three times daily have been used in various clinical trials. At an 80‐mg dose, preservation of pulmonary function with little or no improvement over the baseline was reported. Tobramycin… CONTINUE READING
Topics from this paper
77 Citations
Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods.
- Medicine
- Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
- 2007
- 17
- PDF
Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system.
- Medicine
- Chest
- 2003
- 75
- PDF
Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient.
- Medicine
- The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
- 2005
- 25
Population Pharmacokinetics of Tobramycin Inhalation Solution in Pediatric Patients With Cystic Fibrosis.
- Medicine
- Journal of pharmaceutical sciences
- 2017
- 5
Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization.
- Medicine
- Journal of aerosol medicine and pulmonary drug delivery
- 2016
- 6
Patient-specific modelling of regional tobramycin concentration levels in airways of patients with cystic fibrosis: can we dose once daily?
- Medicine
- The Journal of antimicrobial chemotherapy
- 2017
- 5
- PDF
Inhaled tobramycin-associated hearing loss in an adolescent with renal failure.
- Medicine
- The Pediatric infectious disease journal
- 2006
- 22
Bronchial Hyperreactivity Related to Inhalation Therapy in Cystic FibrosisPatients
- Medicine
- 2014
- 1
- Highly Influenced
- PDF